Revenue Summary of Marksans Pharma Limited

Marksans Pharma Limited's latest annual revenue in 2023 was 21.77 Billion INR , up 17.72% from previous year.
Marksans Pharma Limited's latest quarterly revenue in 2024 Q1 was 5.9 Billion INR , up 5.47% from previous quarter.
Marksans Pharma Limited reported a annual revenue of 18.49 Billion INR in annual revenue 2022, up 24.96% from previous year.
Marksans Pharma Limited reported a annual revenue of 14.8 Billion INR in annual revenue 2021, up 8.17% from previous year.
Marksans Pharma Limited reported a quarterly revenue of 5.6 Billion INR for 2023 Q4, down -4.46% from previous quarter.
Marksans Pharma Limited reported a quarterly revenue of 5.31 Billion INR for 2023 Q2, up 6.24% from previous quarter.

Annual Revenue Chart of Marksans Pharma Limited (2023 - 2004)

Historical Annual Revenue of Marksans Pharma Limited (2023 - 2004)

Year	Revenue	Revenue Growth
2023	21.77 Billion INR	17.72%
2022	18.49 Billion INR	24.96%
2021	14.8 Billion INR	8.17%
2020	13.68 Billion INR	21.17%
2019	11.29 Billion INR	14.38%
2018	9.87 Billion INR	9.21%
2017	9.04 Billion INR	19.14%
2016	7.58 Billion INR	-15.05%
2015	8.93 Billion INR	12.13%
2014	7.96 Billion INR	26.46%
2013	6.29 Billion INR	43.7%
2012	4.38 Billion INR	23.31%
2011	3.55 Billion INR	16.73%
2010	3.04 Billion INR	-15.25%
2009	3.59 Billion INR	-0.21%
2008	3.6 Billion INR	36.44%
2007	2.63 Billion INR	9.07%
2006	2.41 Billion INR	-18.63%
2005	2.97 Billion INR	17.6%
2004	2.52 Billion INR	0.0%

Year	Revenue	Revenue Growth
2024 Q1	5.9 Billion INR	5.47%
2023 Q4	5.6 Billion INR	-4.46%
2023 Q2	5.31 Billion INR	6.24%
2023 Q3	5.86 Billion INR	10.33%
2023 FY	21.77 Billion INR	17.72%
2023 Q1	5 Billion INR	3.43%
2022 Q4	4.83 Billion INR	0.76%
2022 Q3	4.79 Billion INR	6.02%
2022 FY	18.49 Billion INR	24.96%
2022 Q1	4.33 Billion INR	6.49%
2022 Q2	4.52 Billion INR	4.33%
2021 Q4	4.07 Billion INR	12.33%
2021 Q2	3.61 Billion INR	3.51%
2021 Q3	3.62 Billion INR	0.4%
2021 FY	14.8 Billion INR	8.17%
2021 Q1	3.48 Billion INR	8.24%
2020 FY	13.68 Billion INR	21.17%
2020 Q1	3.31 Billion INR	0.2%
2020 Q2	3.56 Billion INR	7.65%
2020 Q3	3.58 Billion INR	0.53%
2020 Q4	3.22 Billion INR	-10.04%
2019 FY	11.29 Billion INR	14.38%
2019 Q1	2.45 Billion INR	4.42%
2019 Q2	2.56 Billion INR	4.64%
2019 Q3	2.87 Billion INR	12.19%
2019 Q4	3.3 Billion INR	14.89%
2018 Q2	2.69 Billion INR	14.37%
2018 Q4	2.34 Billion INR	-5.51%
2018 FY	9.87 Billion INR	9.21%
2018 Q1	2.35 Billion INR	23.31%
2018 Q3	2.48 Billion INR	-7.69%
2017 Q2	2.73 Billion INR	23.86%
2017 FY	9.04 Billion INR	19.14%
2017 Q4	1.9 Billion INR	-12.66%
2017 Q3	2.18 Billion INR	-20.22%
2017 Q1	2.21 Billion INR	19.65%
2016 Q1	1.86 Billion INR	-11.17%
2016 FY	7.58 Billion INR	-15.05%
2016 Q3	2.15 Billion INR	19.29%
2016 Q4	1.84 Billion INR	-14.17%
2016 Q2	1.8 Billion INR	-3.38%
2015 FY	8.93 Billion INR	12.13%
2015 Q2	2.55 Billion INR	21.59%
2015 Q1	2.1 Billion INR	23.24%
2015 Q3	2.17 Billion INR	-14.92%
2015 Q4	2.1 Billion INR	-3.3%
2014 Q4	1.7 Billion INR	-20.05%
2014 Q2	2.1 Billion INR	3.99%
2014 FY	7.96 Billion INR	26.46%
2014 Q1	2.02 Billion INR	29.67%
2014 Q3	2.13 Billion INR	1.34%
2013 Q2	1.61 Billion INR	14.41%
2013 FY	6.29 Billion INR	43.7%
2013 Q4	1.56 Billion INR	-7.5%
2013 Q3	1.68 Billion INR	4.58%
2013 Q1	1.41 Billion INR	13.83%
2012 Q3	1.14 Billion INR	8.58%
2012 Q2	1.05 Billion INR	11.5%
2012 FY	4.38 Billion INR	23.31%
2012 Q1	946.42 Million INR	0.0%
2012 Q4	1.23 Billion INR	8.13%
2011 FY	3.55 Billion INR	16.73%
2010 FY	3.04 Billion INR	-15.25%
2009 FY	3.59 Billion INR	-0.21%
2008 FY	3.6 Billion INR	36.44%
2007 FY	2.63 Billion INR	9.07%
2006 FY	2.41 Billion INR	-18.63%
2005 FY	2.97 Billion INR	17.6%
2004 FY	2.52 Billion INR	0.0%

Peer Revenue Comparison of Marksans Pharma Limited

Name	Revenue	Revenue Difference
Abbott India Limited	58.48 Billion INR	62.772%
Cipla Limited	257.74 Billion INR	91.552%
Gland Pharma Limited	56.41 Billion INR	61.405%
GlaxoSmithKline Pharmaceuticals Limited	34.53 Billion INR	36.954%
Kopran Limited	6.14 Billion INR	-254.285%
NGL Fine-Chem Limited	3.38 Billion INR	-542.894%
Pfizer Limited	21.93 Billion INR	0.719%
Sanofi India Limited	28.51 Billion INR	23.629%
SMS Pharmaceuticals Limited	7.06 Billion INR	-208.215%

Global Stocks Search

Marksans Pharma Limited (MARKSANS.BO)

Revenue Summary of Marksans Pharma Limited

Annual Revenue Chart of Marksans Pharma Limited (2023 - 2004)

Historical Annual Revenue of Marksans Pharma Limited (2023 - 2004)

Peer Revenue Comparison of Marksans Pharma Limited